Doctors should discuss financial concerns of cancer patients (DukeHealth.org)
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Duke researchers describe how breast cancer cells acquire drug resistance (DukeHealth.org)
May 7, 2013
A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.
Cancer studies often lack necessary rigor to answer key questions (DukeHealth.org)
Apr. 29, 2013
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Duke Breast Oncologist Among TIME’s 100 Most Influential People (DukeHealth.org)
Apr. 18, 2013
Kimberly Blackwell, M.D., a clinical oncologist at Duke Cancer Institute and one of the country’s leading breast cancer researchers, is included in this year’s roster of TIME magazine’s 100 most influential people.
Immortality gene mutation identifies brain tumors and other cancers (DukeHealth.org)
Mar. 18, 2013
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
Less Invasive Treatment is Associated with Improved Survival in Early Stage Breast Cancer (DukeHealth.org)
Jan. 28, 2013
Patients with early stage breast cancer who are treated with lumpectomy plus radiation have a better chance of survival compared with those who undergo mastectomy, according to Duke Medicine research.
Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
New Breast Cancer Drug Halts Tumor Growth Better Than Standard Therapy (DukeHealth.org)
June 4, 2012
A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute.
Cardio Fitness Levels of Breast Cancer Patients May Affect Survival (DukeHealth.org)
May 24, 2012
Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical Center.
Cholesterol-lowering drugs may slow benign prostate growth (DukeHealth.org)
May 21, 2012
Statins drugs prescribed to treat high cholesterol may also work to slow benign prostate growth in men who have elevated PSA levels, according to an analysis led by researchers at Duke University Medical Center.
Contact Us
|
Careers
|
Make a Gift
|
Site Map
